Macquarie Group’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Macquarie Group’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-93,236	Closed	-$1.86M	–	2249
2022 Q3	$1.86M	Hold	93,236	–	–	﹤0.01%	1256
2022 Q2	$642K	Hold	93,236	–	–	﹤0.01%	1563
2022 Q1	$867	Hold	93,236	–	–	﹤0.01%	1574
2021 Q4	$1.32M	Hold	93,236	–	–	﹤0.01%	1489
2021 Q3	$2.16M	Hold	93,236	–	–	﹤0.01%	1364
2021 Q2	$2.32M	Hold	93,236	–	–	﹤0.01%	1370
2021 Q1	$2.61M	Buy	93,236 +450	+0.5%	+$16.2K	﹤0.01%	1100
2020 Q4	$3.24M	Hold	92,786	–	–	﹤0.01%	972
2020 Q3	$4.62M	Buy	+92,786	New	+$3.75M	0.01%	852

Macquarie Group's FMTX Position: Q4 2022 in Review

Macquarie Group sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 93,236 shares — an estimated $1.86M sold.

Macquarie Group first reported a position in FMTX in Q3 2020 and held it in 9 quarters. The position peaked at $4.62M in Q3 2020. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Macquarie Group reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Macquarie Group sold 93,236 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $1.86M.
Macquarie Group first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
Macquarie Group's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $4.62M in Q3 2020.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.